Barclays Issues a Buy Rating on Immunocore Holdings (IMCR)

3 days ago · In a report released today, Peter Lawson from Barclays assigned a Buy rating to Immunocore Holdings (IMCR – Research Report), with a price target of $66.00. The …

$66.00
OFF

Barclays Issues A Buy Rating On Immunocore Holdings (IMCR)

2 weeks from now

3 days ago · In a report released today, Peter Lawson from Barclays assigned a Buy rating to Immunocore Holdings (IMCR – Research Report), with a price target of $66.00. The …

businessinsider.com

$66.00
OFF

Immunocore Holdings (IMCR) Receives A Buy From Barclays

2 weeks from now

Aug 9, 2024 · Barclays analyst Peter Lawson maintained a Buy rating on Immunocore Holdings (IMCR – Research Report) today and set a price target of $66.00. The company’s shares …

businessinsider.com

$69.18
OFF

Immunocore Holdings Plc (NASDAQ:IMCR) Receives $69.18 …

2 weeks from now

Nov 19, 2024 · Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the thirteen brokerages that are presently covering …

defenseworld.net

$80
OFF

IMCR Stock Gains After Bullish Views At Barclays Ahead Of Tumor …

2 weeks from now

Nov 30, 2022 · Barclays launched its coverage on the U.K.-based biotech Immunocore Holdings (NASDAQ: IMCR) on Wednesday with an Overweight rating and an $80 per share target as …

seekingalpha.com

$66.00
OFF

Immunocore Holdings (IMCR) Receives A Buy From Barclays

2 weeks from now

Sep 9, 2024 · Barclays analyst Peter Lawson assigned a Buy rating to Immunocore Holdings (IMCR – Research Report) today and set a price target of $66.00. The company’s shares …

businessinsider.com

2%
OFF

Wall Street Analysts Believe Immunocore (IMCR) Could Rally …

2 weeks from now

2 days ago · Immunocore Holdings PLC Sponsored ADR (IMCR) closed the last trading session at $30.40, gaining 5.2% over the past four weeks, but there could be plenty of upside left in …

yahoo.com

1%
OFF

Wall Street Analysts Believe Immunocore (IMCR) Could Rally …

2 weeks from now

3 days ago · The average of price targets set by Wall Street analysts indicates a potential upside of 113.1% in Immunocore (IMCR). While the effectiveness of this highly sought-after metric is …

zacks.com

$92.00
OFF

Immunocore Holdings (IMCR) Receives A Buy From Barclays

2 weeks from now

May 24, 2024 · In a report released today, Peter Lawson from Barclays maintained a Buy rating on Immunocore Holdings ( IMCR – Research Report ), with a price target of $92.00. The …

businessinsider.com

$92.00
OFF

Immunocore Holdings (IMCR) Receives A Buy From Barclays

2 weeks from now

Jan 10, 2023 · In a report released on January 9, Peter Lawson from Barclays maintained a Buy rating on Immunocore Holdings (IMCR – Research Report), with a price target of $92.00.

businessinsider.com

$66.00
OFF

Barclays Gives A Buy Rating To Immunocore Holdings (IMCR)

2 weeks from now

Sep 25, 2024 · Barclays analyst Peter Lawson assigned a Buy rating to Immunocore Holdings (IMCR – Research Report) today and set a price target of $66.00. The company’s shares …

businessinsider.com

$66.00
OFF

Barclays Keeps Their Buy Rating On Immunocore Holdings (IMCR)

2 weeks from now

Nov 7, 2024 · Barclays analyst Peter Lawson maintained a Buy rating on Immunocore Holdings (IMCR – Research Report) today and set a price target of $66.00. The company’s shares …

businessinsider.com

$92.00
OFF

Immunocore Holdings (IMCR) Gets A Buy From Barclays

2 weeks from now

Feb 29, 2024 · Barclays analyst Peter Lawson maintained a Buy rating on Immunocore Holdings ( IMCR – Research Report) yesterday and set a price target of $92.00. The company’s shares …

businessinsider.com

2%
OFF

Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113

2 weeks from now

2 days ago · Immunocore Holdings PLC Sponsored ADR (IMCR) closed the last trading session at $30.40, gaining 5.2% over the past four weeks, but there could be plenty of upside left in …

nasdaq.com

FAQs about Barclays Issues a Buy Rating on Immunocore Holdings (IMCR) Coupon?

Should you buy Immunocore Holdings plc (imcr)?

Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the company, MarketBeat.com reports. ...

Is Immunocore Holdings a good stock to buy?

Immunocore Holdings has an analyst consensus of Strong Buy, with a price target consensus of $81.33, a 170.56% upside from current levels. In a report released on September 16, Capital One Financial also reiterated a Buy rating on the stock with a $90.00 price target. ...

What is the target price for Immunocore (imcr) stock?

14 research analysts have issued 1 year target prices for Immunocore's stock, with a range from $75.15 (on average) to $16.00. This suggests a possible upside of 23.5% from the stock's current price. ...

What is Immunocore Holdings plc?

Immunocore Holdings plc is a biotechnology company founded in 1999 and headquartered in Abingdon, the United Kingdom. ...

Should you buy Lawson & Immunocore holdings?

According to TipRanks, Lawson has an average return of 2.1% and a 43.17% success rate on recommended stocks. Immunocore Holdings has an analyst consensus of Strong Buy, with a price target consensus of $81.33, a 170.56% upside from current levels. ...

What are the share price targets for IMCR?

The IMCR share price targets range from $16.00 to $91.00. On average, analysts predict the company's share price to reach $75.15 in the next twelve months, suggesting a possible upside of 23.5% from the current stock price. ...